Jiaojie Wei

Key Laboratory Of Drug Targeting, No. 17, Southern Renmin Road
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Corrigendum to "enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8+ T cells" [nanomedicine: nanotechnology, biology, and medicine 14 (2018) 2541-2550].

Corrigendum to "enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8+ T cells" [nanomedicine: nanotechnology, biology, and medicine 14 (2018) 2541-2550].

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: June 06, 2025

Corrigendum to "Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence" [Acta Biomaterialia, 136, 2021, 546-557].

Corrigendum to "Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence" [Acta Biomaterialia, 136, 2021, 546-557].

Journal: Acta biomaterialia

Published: February 06, 2025

Correction: Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy.

Correction: Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy.

Journal: The AAPS journal

Published: February 03, 2025

Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.

Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.

Journal: Acta biomaterialia

Published: March 15, 2021

A "dual-guide" bioinspired drug delivery strategy of a macrophage-based carrier against postoperative triple-negative breast cancer recurrence.

A "dual-guide" bioinspired drug delivery strategy of a macrophage-based carrier against postoperative triple-negative breast cancer recurrence.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 07, 2020

Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention.

Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention.

Journal: Acta biomaterialia

Published: October 05, 2018

Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer.

Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer.

Journal: Acta pharmaceutica Sinica. B

Published: September 26, 2018

Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy.

Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy.

Journal: The AAPS journal

Published: August 31, 2018

PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer-Immunity Cycle for melanoma treatment.

PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer-Immunity Cycle for melanoma treatment.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: August 15, 2018

Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways.

Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 09, 2018

Enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8+ T cells.

Enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8+ T cells.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: May 25, 2018

pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.

pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: April 16, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026